Cost-effectiveness of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists for patients with high cardiovascular risk and type 2 diabetes in Canada
在加拿大,钠-葡萄糖协同转运蛋白2抑制剂和胰高血糖素样肽-1受体激动剂对高心血管风险和2型糖尿病患者的成本效益分析
期刊:Canadian Medical Association Journal
影响因子:
doi:10.1503/cmaj.250591
McNally, Ethan S; Marques, Pedro; Possik, Elite; Pandya, Ankur; Tsoukas, Michael A; Mavrakanas, Thomas A; Dasgupta, Kaberi; Gupta, Nisha; Sharma, Abhinav; Russell, W Alton